Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Rang in Aktien #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Aktienkurs
$72.44
Zuletzt synchronisiert: 2026-08-24
Marktkapitalisierung
$20.13B
Veränderung (1 Tag)
1.25%
Veränderung (1 Jahr)
17.60%
Land
DK
Handel Novonesis (Novozymes) B (NSISBC)
Kursverlauf für Novonesis (Novozymes) B (NSISBC)
Höchster Schlusskurs: $67.87 am 2026-08-01

Niedrigster Schlusskurs: $58.74 am 2024-03-01
Kursverlauf der Aktie von Novonesis (Novozymes) B von 2024 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -0.15%
2025 7.42%
2024 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$487.92 2.11%
GB
$198.92 4.22%
FR
$346.89 -5.48%
US
$287.25 3.19%
US
$306.31 4.13%
US